Read on Twitter
A new very large convalescent plasma study (35K patients) came out with positive data this week. Combined with positive news on KMDA’s early trial enrollment and efficacy we believe this is likely why we have seen $KMDA stock price reacting so favorably in recent days.
https://www.medrxiv.org/content/10.1101/2020.08.12.20169359v1.full.pdf [ http://medrxiv.org ]
The study continues to add to pile of efficacy data supportive of convalescent plasma efficacy in Covid-19. Another large study and meta-analysis of studies below:
https://www.wsj.com/articles/convalescent-plasma-reduced-death-rate-among-covid-19-patients-study-data-signals-11596594390 [ http://wsj.com ]
The study continues to add to pile of efficacy data supportive of convalescent plasma efficacy in Covid-19. Another large study and meta-analysis of studies below:
https://www.wsj.com/articles/convalescent-plasma-reduced-death-rate-among-covid-19-patients-study-data-signals-11596594390 [ http://wsj.com ]
Convalescent plasma continues to show better efficacy data than Remdesivir and other treatments.
Interestingly the concentration of IG in this study showed a trend which suggested more concentration led to better efficacy outcomes. Hyperimmunes are hyper concentrated therefore
Interestingly the concentration of IG in this study showed a trend which suggested more concentration led to better efficacy outcomes. Hyperimmunes are hyper concentrated therefore
efficacy for Kamada’s product should theoretically be even better than concentrated plasma.
We also found it interesting that earlier treatment with plasma led to better outcomes. This suggests that plasma should likely be used earlier in a Covid treatment regimen, potentially
We also found it interesting that earlier treatment with plasma led to better outcomes. This suggests that plasma should likely be used earlier in a Covid treatment regimen, potentially
as a “first line” treatment for hospitalizations and would support a larger TAM for Kamada’s Covid-19 hyperimmune.
Convalescent covid plasma continues to show excellent safety data as well.
Convalescent covid plasma continues to show excellent safety data as well.
